Five patients with advanced systemic scleroderma were treated with high doses of D-penicillamine for periods up to 11 months. Careful measurement of mobility of involved joints before and after therapy revealed no improvement. Side effects occurred in all patients.
No takes yet. Share an insight, caveat, or question.
David D. Fulghum (1968) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: